📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1-S Cell-Cycle Transition (2022)

First Author: Zhang J

Attributed to: The University of Manchester (UoM) bid for phase 7 of MRC Confidence in Concept (CiC) funding funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2767-9764.crc-21-0089

PubMed Identifier: 36466034

Publication URI: http://europepmc.org/abstract/MED/36466034

Type: Journal Article/Review

Parent Publication: Cancer Research Communications

Issue: 3

ISSN: 2767-9764